AI Science Tracker

Sybil: lung-cancer risk prediction up to six years from a low-dose CT

MIT; Mass General Cancer Center and Chang Gung Memorial Hospital · 20 Jan 2023 · medicine

Discovery

Sybil: lung-cancer risk prediction up to six years from a low-dose CT

The model predicts risk from a single CT with a six-year C-index of 0.75 (NLST), 0.81 (MGH) and 0.80 (CGMH), and a one-year ROC area between 0.86 and 0.94. Retrospective validation on three independent datasets; trained only on smokers, with prospective testing and testing in nonsmokers as next steps.

Technology: Sybil (neural network on CT scans)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: The model was trained on NLST low-dose CT scans and validated on a held-out NLST set and two independent cohorts (MGH and CGMH), with six-year C-index 0.75, 0.81 and 0.80; the abstract describes no prospective testing.
  • Still unknown: The abstract states that future study is required to understand clinical applications; the press release says prospective testing and testing in nonsmokers are next steps.
  • AI role: A deep learning model predicts lung-cancer risk from a single low-dose chest CT.

Evidence sources: https://news.mit.edu/2023/ai-model-can-detect-future-lung-cancer-0120 · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1200/JCO.22.01345&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 332 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.